Related Experiment Video
Updated: Apr 21, 2026

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
Cancer resistance as an acquired and inheritable trait
Janne Koch1, Jann Hau2, Henrik Elvang Jensen3
1Department of Experimental Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark Institute of Veterinary Pathology, Faculty of LIFE Sciences, University of Copenhagen, Frederiksberg, Denmark jako@sund.ku.dk.
Aim:
To induce cancer resistance in wild-type mice and detect if the resistance could be inherited to the progeny of the induced resistant mice. Furthermore to investigate the spectrum and immunology of this inherited cancer resistance.
Materials And Methods:
Resistance to with live S180 cancer cells in BALB/c mice was induced by immunization with inactivated S180 cancer cells. The immunization was performed by either frozen/thawed or irradiated cancer cells or cell-free ascitic fluid (CFAF).
Results:
In all instances the induced resistance was demonstrated to be inheritable. The phenotype was named HICR (heritable induced cancer resistance) and was defined as primary resistant progeny from mice immunized with frozen/thawed or irradiated S180 cells or CFAF obtained from mice with S180 induced ascites. Notably, this resistance was transferred from both male and female mice to the offspring of the immunized mice for at least two generations. Although inheritable, the frequency of cancer-resistant pups was lost over a few generations. Cells from the J774A.1 and RAW cancer cell lines did not induce inheritable cancer resistance, and C57BL/6 mice could not pass on cancer resistance fluorescence-activated cell sorting (FACS) analyses of the peritoneal cells revealed an increased fraction of macrophages. In necropsies of resistant mice no histological signs of cancer or other disease was found.
Conclusion:
Only materials derived from S180 cells could give rise to HICR mice. The molecular basis of the resistance is unknown but may involve epigenetic mechanisms. Other examples of inheritability of acquired phenotypic changes exist but, to our knowledge, this is the first demonstration of acquired, inherited cancer resistance.
Insights
Researchers induced cancer resistance in mice, finding it inheritable to offspring for at least two generations. This heritable induced cancer resistance (HICR) phenomenon, observed with S180 cells, offers a novel insight into acquired immunity.
Area of Science:
- Immunology
- Genetics
- Cancer Biology
Background:
- Acquired resistance to cancer is a significant challenge in oncology.
- Investigating mechanisms of inherited immunity could offer new therapeutic avenues.
Purpose of the Study:
- To induce cancer resistance in mice and determine if it is heritable.
- To characterize the spectrum and immunological basis of this inherited resistance.
Main Methods:
- BALB/c mice were immunized with inactivated S180 cancer cells (frozen/thawed, irradiated, or cell-free ascitic fluid).
- Progeny of immunized mice were assessed for cancer resistance.
- Flow cytometry (FACS) analyzed peritoneal cell populations.
Main Results:
- Induced cancer resistance was inheritable to offspring for at least two generations, termed heritable induced cancer resistance (HICR).
- Resistance was only observed with S180 cell-derived materials, not other cell lines.
- Resistant mice showed an increased fraction of macrophages and no signs of cancer.
Conclusions:
- Heritable induced cancer resistance (HICR) is demonstrable and inheritable from S180 cell immunization.
- The molecular basis is unknown but may involve epigenetic modifications.
- This study presents the first evidence of acquired, inherited cancer resistance.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Cancer Prevention
Some...
Cancer Prevention
Cancers Originate from Somatic Mutations in a Single Cell